ask="N/A"
ask_size="N/A"
average_daily_volume="128011"
bid="8.00"
bid_size="400"
book_value="3.76"
change="+0.10"
change_from_200_day_moving_average="0.12"
change_from_50_day_moving_average="0.28"
change_from_52_week_high="-4.43"
change_From_52_week_low="2.48"
change_in_percent="+1.25%"
close="8.07"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.82"
ebitda="-8.84M"
eps_estimate_current_year="-2.31"
eps_estimate_next_quarter="-0.52"
eps_estimate_next_year="-2.53"
ex_dividend_date="N/A"
float_shares="7732000"
high="8.14"
high_52_weeks="12.50"
last_trade_date="3/17/2017"
last_trade_price="8.07"
last_trade_size="57668"
last_trade_time="4:00pm"
low="7.83"
low_52_weeks="5.59"
market_capitalization="153.73M"
moving_average_200_day="7.95"
moving_average_50_day="7.79"
name="Recro Pharma
Inc."
notes="N/A"
one_year_target_price="20.00"
open="7.97"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+1.47%"
percent_change_from_50_day_moving_average="+3.61%"
percent_change_from_52_week_high="-35.44%"
percent_change_from_52_week_low="+44.36%"
previous_close="7.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.12"
price_per_sales="2.19"
revenue="69.34M"
shares_outstanding="19050000"
short_ratio="5.77"
stock_exchange="NCM"
symbol="REPH"
volume="256127"
weeks_range_52="5.59 - 12.50"
